Indonesia suspends sale of all syrup medicines

The deaths of around 100 children in Indonesia have prompted the country to suspend sales of all syrup and liquid medication. Indonesia said some syrup medicine was found to contain ingredients linked to acute kidney injuries (AKI), which have killed 99 young children this year. It is not clear if the medicine were imported or locally produced. It comes just weeks after a cough syrup in The Gambia was linked to the deaths of nearly 70 children. On Thursday, Indonesian health officials said they had reported around 200 cases of AKI in children, most of who were aged under five. Earlier this month, the World Health Organization (WHO) issued a global alert over four cough syrups that were linked to the deaths of almost 70 children in The Gambia.

 The WHO found the syrups used there – made by an Indian pharmaceutical company – contained “unacceptable amounts” of diethylene glycol and ethylene glycol. The syrups have been “potentially linked with acute kidney injuries”, said the organisation. Indonesia’s Health Minister on Thursday said the same chemical compounds were also found in some medicines used locally. Indonesian authorities said the cough syrups used in The Gambia were not sold locally. One epidemiologist said the true death toll could be even higher than reported. Indonesian authorities have so far not disclosed the brands or types of syrup medicines linked to sick children – instead just temporarily banning the sale and prescription of all syrup and liquid medicines.